# KOSELUGO
> **NDA213756** · New Drug Application · Sponsor: ASTRAZENECA · Approved 2020-04-10
## Drug
- **FDA Application Number:** NDA213756
- **Application type:** New Drug Application
- **Brand name:** KOSELUGO
- **Generic name:** SELUMETINIB
- **Active ingredients:** SELUMETINIB SULFATE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ASTRAZENECA
- **Manufacturer:** AstraZeneca Pharmaceuticals LP
- **First approval:** 2020-04-10
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213756)
---
*AI Analytics · CC0 1.0*